What Next for Allscripts Healthcare Solutions (NASDAQ:MDRX) Stock After Increase in Shorted Shares?

February 15, 2018 - By Clifton Ray

 What Next for Allscripts Healthcare Solutions (NASDAQ:MDRX) Stock After Increase in Shorted Shares?

Investors sentiment decreased to 1.16 in Q3 2017. Its down 0.29, from 1.45 in 2017Q2. It fall, as 22 investors sold Allscripts Healthcare Solutions, Inc. shares while 72 reduced holdings. 44 funds opened positions while 65 raised stakes. 195.75 million shares or 0.88% less from 197.48 million shares in 2017Q2 were reported.
Oregon Public Employees Retirement Fund reported 66,898 shares stake. Swiss Comml Bank stated it has 0% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Laurion Capital Mgmt Lp has invested 0% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). First Commercial Bank Of Omaha, a Nebraska-based fund reported 210,680 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 36,627 shares. Royal Financial Bank Of Canada has 1.17 million shares for 0.01% of their portfolio. Metropolitan Life Insur Comm New York holds 0.03% of its portfolio in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) for 288,223 shares. Sentinel Asset Mgmt holds 0.24% or 716,320 shares in its portfolio. 811 were reported by Advisory Svcs Ntwk Ltd Limited Liability Company. Panagora Asset Management has invested 0% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Weaver C Barksdale & Associates holds 0.01% or 632 shares. Bnp Paribas Arbitrage owns 178,967 shares. 13,400 were reported by Cambridge Inc. 82,975 are held by Cantab Capital Prtnrs Llp. Blue Harbour Group Incorporated L P stated it has 1.99% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX).

Since September 14, 2017, it had 0 buys, and 6 selling transactions for $974,699 activity. The insider Farley Brian sold $67,607. $215,292 worth of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) was sold by Black Paul on Thursday, December 14.

The stock of Allscripts Healthcare Solutions (NASDAQ:MDRX) registered an increase of 7.07% in short interest. MDRX’s total short interest was 15.58 million shares in February as published by FINRA. Its up 7.07% from 14.55 million shares, reported previously. With 2.33 million shares average volume, it will take short sellers 7 days to cover their MDRX’s short positions. The short interest to Allscripts Healthcare Solutions’s float is 9.19%.

The stock increased 2.53% or $0.365 during the last trading session, reaching $14.815. About 1.48 million shares traded. Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has declined 8.32% since February 15, 2017 and is downtrending. It has underperformed by 25.02% the S&P500.

Allscripts Healthcare Solutions, Inc. provides information technology and services to healthcare organizations in the United States, Canada, and internationally. The company has market cap of $2.68 billion. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. It currently has negative earnings. The companyÂ’s Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Ratings Coverage

Among 26 analysts covering Allscripts-Misys Healthcare (NASDAQ:MDRX), 12 have Buy rating, 1 Sell and 13 Hold. Therefore 46% are positive. Allscripts-Misys Healthcare had 60 analyst reports since August 5, 2015 according to SRatingsIntel. KeyBanc Capital Markets maintained Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) on Wednesday, September 20 with “Hold” rating. The stock has “Buy” rating by Jefferies on Friday, October 16. On Tuesday, October 17 the stock rating was maintained by Robert W. Baird with “Buy”. RBC Capital Markets maintained Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) on Friday, February 19 with “Outperform” rating. RBC Capital Markets maintained Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) rating on Sunday, October 29. RBC Capital Markets has “Buy” rating and $17.0 target. The stock of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) earned “Hold” rating by Deutsche Bank on Thursday, November 10. The firm earned “Sector Perform” rating on Wednesday, August 5 by RBC Capital Markets. The stock of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has “Outperform” rating given on Monday, September 11 by Cowen & Co. The company was downgraded on Tuesday, December 13 by Morgan Stanley. As per Tuesday, January 5, the company rating was maintained by Topeka Capital Markets.

More important recent Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) news were published by: Nasdaq.com which released: “RSI Alert: Allscripts Healthcare Solutions (MDRX) Now Oversold” on February 08, 2018, also Globenewswire.com published article titled: “Allscripts Names Dennis Olis Chief Financial Officer”, Prnewswire.com published: “Quotidian Technical Highlights on Selected Application Software Stocks — 2U …” on February 13, 2018. More interesting news about Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) was released by: Gurufocus.com and their article: “Community Trust & Investment Co Buys MasTec Inc, Allscripts Healthcare …” with publication date: January 26, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.